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p¼0.008). In donors younger than 55 years, loss of eGFR (in ml/min/1.73m2 per year)
was significantly increased in donors with hypertension at baseline, whereas in donors
older than 55 years, the difference was not statistically significant (table 1).
CONCLUSIONS: Arterial hypertension and age at time of donation are strong predic-
tors for adverse renal outcomes in living kidney donors.
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INTRODUCTION AND AIMS: Acute tubular necrosis (ATN), a frequent histopatho-
logical feature in the early post renal transplant biopsy, affects graft function on the
long term. Appropriate markers to identify patients at risk of absent or incomplete
recovery after delayed graft function are lacking.
METHODS: In this study, we included first 41 renal transplanted patients who had a
biopsy during the first month after transplantation showing ATN lesions. Using micro-
vascular endothelial (fascin, vimentin) and tubular epithelial (vimentin, kim1) activa-
tion/injury markers detected by immunohistochemistry,
RESULTS: we found a significant association of microvasculature endothelial activa-
tion in early biopsies of patients with no or partial graft recovery (rho¼ -0.55,
p¼0.0005 for spearman’s correlation of endothelial activation marker fascin expression
with eGFR at 24 month post transplant)(figure). A strong correlation between
extensive ATN, scored by morphometry, and a poor graft function at 24 month post
transplant, (spearman’s correlation with rho¼ -0.64, p¼0.003) was found only in the
patients with the endothelial activation markers but not in those without these markers.
This suggests an implication of microvascular injury in early ATN and late graft loss.
The predictive value of microvascular endothelial activation for worse renal graft out-
come was confirmed in a second transplant center with 40 early biopsy with ATN.
CONCLUSIONS: These results suggest a detrimental role of endothelial cell activation
at the early phase of renal transplantation. Only those with EndMT marker expression,
extensive ATN could predict poor graft recovery.
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INTRODUCTION AND AIMS: Delayed graft function (DGF) is a manifestation of
acute kidney injury resulting from ischemia-reperfusion injury. It has usually been
defined as the need for dialysis within 7 days after transplantation. Aim of our study
was to evaluate effect of DGF on progression of chronic renal changes in transplanted
kidney, one year after transplantation.
METHODS: Our study is a retrospective one. We included 163 consecutive patients
transplanted in our centre from 2007 to 2014. Kidney graft recipients, both from living
and deceased donors and kidney pancreas recipients were included.The primary out-
come was progression of chronic histological changes during first year post-transplant,
based on biopsies performed on the day of transplantation and at 12 months post-
transplant. We used composite chronic histological score as a marker of chronic graft
damage. The composite score consisted of a sum of Banff chronic scores ci, ct, ah and
cv (therefore, score value range 0-12). We analysed the difference of the one-year
change in composite score between group of patients with and without DGF on paired
biopsies. We also analysed impact of DGF on graft survival in our cohort of patients.
RESULTS: There were 60 patients with DGF (36,8%) in our cohort. Follow up was
16656590 days. Chronic composite histological score was significantly higher in biop-
sies at 12 months after transplantation (3.56 62.,93 at 12 months biopsies vs.
1.9262.16 at 0 biopsies, p<0,001). In univariate analysis, DGF was correlated with
composite chronic histological score and with the change of the score. In a multivariate
analysis DGF was not correlated with change of the score (p¼0,012). Graft and patient
survival was similar in both groups.
CONCLUSIONS: Delayed graft function does not seem to be major drive of a chronic
allograft injury during first post-transplant year, and does not seem to increase progres-
sion of fibrosis.
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INTRODUCTION AND AIMS: GFR Decline 30% over 2 years is a surrogate that
can substitute to the conventional “doubling of serum creatinine” to predict CKD-
related complications, especially ESRD, in patients with native kidneys. While CKD
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trajectory is less predictable in transplanted patients, recent data have suggested that
similar GFR decline might also be an acceptable proxy for long-term transplant out-
come. We sought (i) to confirm the prognostic value of an early GFR decline 30% in
kidney transplant recipients and (ii) to determine whether using direct measurement of
GFR with inulin can improve the performance of this surrogate for predicting graft fail-
ure and recipients mortality.
METHODS: We retrospectively analyzed all recipients transplanted between January
1989 and December 2000, having a functioning graft at 5 years’ post-transplant and for
whom inulin-measured GFR was available at 1 and 5 years’ post-transplant with con-
comitant CKD-EPI estimated GFR. Prognostic evaluation of GFR change between years
1 to 5 as a risk factor for graft failure and all-cause mortality was conducted for a fixed
follow-up of 11 years after the 5th anniversary of transplantation by evaluating discrimi-
nation (time-dependent ROC AUC) and calibration (subdistribution hazard ratio with
competing risk model).
RESULTS: Out of 417 kidney transplant recipients, 116 patients had lost their graft and
77 had died with a functioning graft 16 years after transplantation. While being signifi-
cantly associated with graft failure (sHR¼2.37 [1.47-3.83]), CKD-EPI calculated GFR
decline 30% failed to appropriately predict long term graft survival (C statistics of
0.63). Concordance between inulin-measured GFR and CKD-EPI-estimated GFR to
detect patients with similar GFR change was only 53%. Inulin-measured GFR change
was however not better in predicting 16 years’ post-transplant graft loss (C statistics of
0.59). Comparable results were observed for all-cause mortality and for other thresh-
olds of GFR decline (20% and 50%).
CONCLUSIONS: Our data suggest that early GFR decline is a poor surrogate for long
term transplant outcome, even when change in GFR is directly measured by a reference
method. Whether combining evaluation of GFR decline with other parameters (e.g.
albuminuria) can refine prediction needs to be tested.
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INTRODUCTION AND AIMS: Fracture risk is increased after kidney transplantation,
but how to identify those that may benefit from intervention remains unclear. New
guidelines published in 2017 advocate bone mineral density (BMD) testing to assess
fracture risk, but the evidence is sparse. The purpose of this study was to investigate the
predictability of BMD on fracture after kidney transplantation.
METHODS: Adult patients receiving a kidney transplant from Oct 2006 until Oct
2011, as well as post-transplant fractures in the cohort from Oct 2006 to Dec 2014, were
identified from national registries. Dual energy x-ray absorptiometry (DEXA) scans
and blood tests were performed 10 weeks post-transplant. Time to event analyses were
performed with risk estimates expressed as Cox regression hazard ratio (HR) with 95%
confidence interval (CI). Adjusted analyses included body mass index (kg/m2), eGFR
(ml/min/1.73m2), dialysis therapy before transplantation (y/n), diabetic nephropathy
(y/n), and living donor (y/n).
RESULTS: Of all patients receiving a kidney transplant in the study period (n¼ 1 272),
68% (n¼ 860) had an available DEXA-scan. Median age at the time of transplantation
was 54 years (range 18 to 82), and 69% were men (n¼ 591). A living donor was used in
34%, 70% had received dialysis therapy prior to transplantation (n¼ 438 hemodialysis,
n¼ 165 peritoneal dialysis), and 15% had diabetic nephropathy. Median eGFR 10
weeks post-transplant was 59 mL/min/1.73 m2 (range 22 to 113). During a median fol-
low-up of 5.6 years (range 39 days to 8.3 years), 77 patients experienced a fracture.
Women were more likely to fracture than men (HR 1.70, CI 1.08 to 2.66, p¼ 0.02), and
older age was also associated with increased risk (HR per 5 years 1.12, CI 1.03 to 1.22, p
¼ 0.008). A T-score -2.5 predicted fracture in unadjusted (Figure 1) and adjusted
analyses (HR 1.85, CI 1.14 to 3.01, p¼0.01). A 1 unit decrease in T-score at any site was
associated with increased risk of fracture (Table 1).
CONCLUSIONS: DEXA assessed BMD may identify patients at risk of fracture after
kidney transplantation. Whether antiresorptive treatment will decrease fracture risk
post-transplant remains to be investigated.
Table 1: Risk of fracture by a 1 unit decrease of T-score in adult kidney transplant
recipients
HR 95% CI p
Total hip 1.50 (1.20 to 1.88) <0.001
Lumbar spine 1.33 (1.13 to 1.56) <0.001
Distal 1/3 radius 1.22 (1.03 to 1.45) <0.02
Ultradistal radius 1.17 (1.02 to 1.33) <0.02
Adjusted analyses
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INTRODUCTION AND AIMS: Successful kidney transplantation (KTx) is the opti-
mal treatment for patients with end stage renal disease (ESRD). Many older patients
experience good health-related quality of life (HRQoL) in modern dialysis while immu-
nosuppressive drugs are known to have side effects with negative impact on HRQoL.
There is a lack of knowledge regarding HRQoL after KTx in elderly recipients. The aim
of this study was to measure HRQoL longitudinally in patients65 years of age, from
time of enlisting for KTx and until 3 year post transplant.
METHODS: Single center prospective study including patients 65 years at enlisting
for KTx. Participants were asked to complete the Kidney Disease Quality of Life Short
Form version 1.3 questionnaire at enlisting and thereafter every 6 months until KTx,
withdrawal or death. Post-transplant, the patients received a new form after 6 months,
1 and 3 years. All patients received prednisolone, tacrolimus and mycophenolate
mofetil.
RESULTS: A total of 289 patients have been included. By the end of 2017 a total of 203
patients had been transplanted and 68 patients had reached and completed the 3-year
post-transplant questionnaire (96% response rate). Mean age at Ktx was 71 years (65-82),
77% male, 27% were not in dialysis and 27% got a kidney from a living donor. When
comparing the last HRQoL scores pre-tx with 3-year post-tx, there is a statistical signifi-
cant increase in 9 of 15 domains (fig 1). Already 6 months after KTx the HRQoL scores
improved, between 1 and 3 years the scores remained stable with a few exceptions:
Physical Function showed a slight decrease during the period (76-71). Social Function
remained stable at pre-tx level until 1 year post KTx, then having a statistical significant
increase (66-82). Mental Health increased significantly after 6 months, then stabilized at a
not -significant level compared to pre-tx at 1 year (88-83). The kidney disease specific
domains remained stable at a high level. Graft function remained stable with mean s-crea-
tinine 126 lmol/l (SD634) at one year and 120 lmol/l (SD636) at three years.
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